As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Featured article by Andrea Murru and colleagues: Lithium’s antiviral effects: a potential drug for CoViD-19 disease?
In this review, authors examined the preclinical and clinical evidence on the antiviral effects of lithium, offering a perspective for its potential use in clinical settings.
Articles
-
-
Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife)
-
Treating winter depressive episodes in bipolar disorder: an open trial of light therapy
-
Sleep and physical activity in patients with newly diagnosed bipolar disorder in remission, their first-degree unaffected relatives and healthy controls
-
Lithium’s antiviral effects: a potential drug for CoViD-19 disease?
Announcing the launch of In Review
International Journal of Bipolar Disorders, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
See the full range of benefits of In Review and how to opt-in
Thematic Series: Controversies in Bipolar Disorders
This collection of articles aims to present areas of controversy and uncertainty in bipolar disorder seeking to identify reasons for some of the dilemmas and future solutions to it. Read the series here.
Further submissions of review articles on the topic are encouraged, please submit here.
Aims and scope
International Journal of Bipolar Disorders is a peer-reviewed, open access online journal publishing contributions from the broad range of clinical, psychological and biological research in bipolar disorders. It collaborates with the International Group for the study of Lithium Treated Patients (IGSLi) and the Deutsche Gesellschaft für Bipolare Störungen (DGBS), and serves as the official journal of these organisations. International Journal of Bipolar Disorders invites clinicians and researchers from around the globe to submit original research articles, short research communications, reviews, guidelines, case reports, study protocols and letters to the editor that help to enhance understanding of bipolar disorders. The journal makes all articles freely available to researchers worldwide, ensuring maximum dissemination of content. Content is published online continuously to provide timely communication to the community and keep publication times to a minimum.
Society affiliation
International Journal of Bipolar Disorders is affiliated with IGSLI (International Group for The Study of Lithium Treated Patients)
Affiliated with
Annual Journal Metrics
-
Speed
45 days to first decision for reviewed manuscripts only
44 days to first decision for all manuscripts
80 days from submission to acceptance
52 days from acceptance to publicationCitation Impact
3.550 - 2-Year Impact Factor
1.164 - Source Normalized Impact per Paper (SNIP)Usage
152,018 Downloads
185 Altmetric Mentions
- ISSN: 2194-7511 (electronic)
